EP1800645A1 - Package for medicinal products and the like - Google Patents

Abstract

The packaging (10) has a substrate (14) equipped with one or several preassembled, closed product carriers (16), which contain multiple, individual medicinal products (11) for a defined period of time, and provided with instructions for application and/or the administration time for the patient. Each product carrier contains exclusive products of a special active substance or a special active substance combination in a special dosage. An independent claim is also included for a method for production of packaging.

Description

The invention relates to a packaging for pharmaceutical and / or medical products and / or dietary supplements, comprising a substrate which is equipped with patient-specific products for a defined period of time and provided with instructions on the application or administration time for the patient. Furthermore, the invention relates to a method for producing a packaging for pharmaceutical and / or medical products.

For the primary packaging of pharmaceutical and / or medical products and / or dietary supplements (which are also referred to as products below), by way of example his tablets, dragees, ampoules, vitamin preparations but also syringes or the like mentioned, different requirements are important. On the one hand, there are constant efforts to make it easier for the patient to take the medication or to use the products. The existing packaging support the patient in addition to the simplified removal of the product from the packaging by appropriate removal aids in the dosage and the temporal intake of the drugs. These aspects are commonly known by the terms "convenience" or "senior friendliness" (SF). On the other hand, the child safety aspect (CR) is of increasing regulatory importance. The common packaging is therefore secured by various measures against unauthorized removal, especially by children.

Especially with pharmaceutical and / or medical products, however, the reliability of compliance with the prescribed medicines is of particular importance, which should be supported by so-called compliance packaging. It has been found that patients more reliably take the medication prescribed to them when one or more and / or different medicaments are arranged side by side or together within a package and the required application or administration times are indicated by calendars and times. For example, in addition to antibiotics, stomach protection preparations are to be taken at the same time. The arrangement or compilation of the drugs by day of the week and time of day makes it easier for the patient to take his prescribed medication reliably, which is particularly important for chronically ill patients of particular importance.

Commercially available packages containing several different products are known. For example, such packages have a so-called blister with products from two cooperating manufacturers. However, the number of products within a package as well as the allocation or combination of products in all packages of this type is always the same and standardized. In other words, a therapy-specific but no patient-specific care by such packaging is possible.

On the market further packaging are known and available, which ensure a patient-specific compilation of one or more products. The products are filled either directly as raw material or after unpacking from a package in the appropriate patient-specific packaging. However, this requires, on the one hand, that the filling must be carried out under clean room conditions and with pharmaceutical specialists, which leads to very high costs. On the other hand, the unpacking and re-packaging is complicated and expensive due to the multitude of work steps. Moreover, the packaging of medicines from raw materials and the handling of raw materials after unpacking are subject to special legal conditions, the fulfillment of which means a considerable outlay. In the known and produced by the methods described above packages may be, several different products / tablets in a receiving space, such as a bag, a tubular bag, a nest of a Blister pack or the like, arranged. However, this is particularly disadvantageous because of the risk of cross-contamination.

It is therefore an object of the present invention to provide a secure, cost-effective and patient-specific packaging. Furthermore, it is an object of the invention to propose a corresponding method for producing the packaging.

The object is achieved on the one hand by a package having the features mentioned above in that one or more prefabricated product carriers are arranged with the patient-specific products for a defined period of time on the substrate, each product carrier being part of a blister pack and excluding products of a specific active ingredient or a special combination of active ingredients in a special dosage contributes. This individual packaging is created in a particularly simple and cost-effective manner, since the packaging individual or different products can be assigned in freely selectable amount. A key advantage is that the products are protected from the actual manufacturing to the opening / removal by the patient. The problems with handling raw materials can be circumvented with this packaging. But that also means that a wide variety of products can be brought together by different manufacturers from a third party.

Preferably, the substrate carries or forms a blister composite, such that a plurality of sections of the product-specific blister packs, each with different products, are applied by one or more manufacturers to the substrate. Through the packaging according to the invention, for the first time, a package is created which combines products packaged in a particularly simple manner with several manufacturers and presents them in a patient-individual manner.

Advantageously, exactly one product is arranged in each nest of each blister pack or each section of the blister packs. This can be in addition to the Prevention of cross-contamination of the further abrasion of the products can be prevented. Every product is optimal and maximally protected,

In a preferred embodiment of the invention, the packaging is produced fully automatically. As a result, a faultless assembly of the products is guaranteed to a packaging, so that incorrect medications are avoided. The automatic production also ensures the required cost-effectiveness of the packaging.

On the other hand, the object is achieved by a method for producing a packaging for pharmaceutical and / or medical products and / or dietary supplements by the following steps: providing a substrate, selecting patient-specific products for a defined period of time, separating pre-assembled product carriers with the selected patient-specific products of blister packs in which each product carrier carries exclusively products of a specific active substance or a specific combination of active substances in a specific dosage, and equipping the substrate with the separated product carriers. By this method, it is possible in a particularly simple way to produce patient-specific packaging, since the individual products can be separated without unpacking and repackaging in the desired amount of the blister pack and assembled to form a Blisterverbundes. By virtue of the fact that the products are always protected, ie from the manufacture to the point of removal by the patient in the nest of the blister pack, the compilation of the products into a specific packaging can also be carried out by third parties who are not manufacturers of pharmaceutical products / medicaments , This increases the flexibility in the production of the final packaging.

Preferably, the or each product carrier is separated from a roll-up blister strip. These blister straps may be machine-operable and prefabricated, ie, for example, rolled-up or folded blister carriers. This ensures a particularly simple provision of different products, even from different manufacturers on a device for the production of packaging.

Advantageously, the packaging is made automatically, which can reduce errors in the selection and compilation of the products.

Fig. 1

eine schematische Darstellung einer Verpackung mit einer beispielhaften patientenspezifischen Zusammenstellung der Medikamente,

Fig. 2

eine Vergrößerung des Ausschnitts II in der Figur 1,

Fig. 3

eine schematische Darstellung einer weiteren Verpackung mit einer patientenspezifischen Zusammenstellung der Medikamente,

Fig. 4

eine schematische Darstellung einer weiteren Verpackung mit einer patientenspezifischen Zusammenstellung der Medikamente,

Fig. 5

eine schematische Darstellung einer weiteren Verpackung mit einer patientenspezifischen Zusammenstellung der Medikamente,

Fig. 6

eine schematische Schnittdarstellung der Verpackungen gemäß der Figuren 1 bis 5, und

Fig. 7

eine schematische Darstellung einer Vorrichtung zur Herstellung von Verpackungen gemäß der Figuren 1 bis 5.

Further advantageous features and further developments of the packaging as well as further preferred method steps emerge from the subclaims and the description. The packaging and the manufacturing process will be explained in more detail with reference to the accompanying drawings. In the drawing shows:

Fig. 1

a schematic representation of a package with an exemplary patient-specific compilation of the drugs,

Fig. 2

an enlargement of section II in FIG. 1,

Fig. 3

a schematic representation of another packaging with a patient-specific compilation of drugs,

Fig. 4

a schematic representation of another packaging with a patient-specific compilation of drugs,

Fig. 5

a schematic representation of another packaging with a patient-specific compilation of drugs,

Fig. 6

a schematic sectional view of the packaging according to the figures 1 to 5, and

Fig. 7

a schematic representation of an apparatus for the production of packages according to the figures 1 to 5.

The packaging described below is used for patient-specific and individual care of patients with pharmaceutical and / or medical Products and / or nutritional supplements. In particular, the packages are used to hold tablets, dragees or the like.

Each of the packages 10 shown is provided or equipped with products 11 for a defined period of time, whereby the therapy can last for a very long time, in particular for chronically ill patients. In this case, the time period as in the embodiments shown may be e.g. be defined as weekly calendar 12. However, monthly or quarter graduations may also be provided on the packages 10. In addition to the period, the packaging 10 has instructions or information 13 about the actual application or administration times.

The package 10 comprises a substrate 14, which may be made of cardboard, plastic or other suitable materials. The substrate 14 may be planar or, as in the exemplary embodiments, designed as a folding element 15, for example, to form a so-called wallet packaging. The above-mentioned weekly calendar 12 and the information 13 are on the substrate 14 preferably existing as a blank, e.g. applied by printing, embossing or the like.

On the substrate 14 prescription and / or pharmacy and / or freely available products 11 are arranged. These products 11 are protected on or within product carriers 16. The product carriers 16 are part of a prefabricated (not explicitly shown) type of packaging, in particular a blister pack. The prefabricated product carriers 16 are subdivided into sections 17 by separating them from the blister pack, each section 17 having exclusively products 11 of one type or, more precisely, of a specific active substance or a specific combination of active substances with a defined dose. In other words, each product type is associated with its own product carrier 16. The product carriers 16 and / or sections 17 have so-called nests 18 in a manner customary for blister packs, each of which is designed to receive a single product 11. In other words, each nest 18 is assigned only a single product 11. Preferably, each product 11 of the product carrier 16 is individually identified uniquely with a corresponding optical code. The nests 18 are covered or closed by a film 26 or the like. The single ones The product carrier 16 or the corresponding sections 17 form a blister composite 19 with the substrate 14. Such a blister composite 19 can accordingly have a plurality of sections 17 separated from a blister strip, the sections 17 being identical or different products 11 from one or more manufacturers may include. Sections 17 are administered in the form of a matrix with columns and rows, with a first section 17 one or more separately housed in a nest 18 copies example of a drug A and a second section 17 one or more separately housed in a nest 18 Examples of a drug B has. The number of rows and the number of columns correspond to an x-times intake on one day and a y-days extending income period. It is basically possible, of course, to separate product carriers 16 or sections 17 from any desired supply pack or blister pack. Examples are blister magazines, blister strips or other carriers which have a plurality of nests 18 arranged one next to and / or next to one another. Also, the separation of conventional blister carriers with eg 2x5 tablets is possible.

Depending on the need, requirement or recipe, the products 11 are individually selected and applied with their respective Produktträgem 16 on the substrate 14. In this case, the product carriers 16 or the sections 17 are firmly connected to the substrate 14, for example by heat bonding or the like. However, other common mounting options or means are also possible. The substrate 14 itself can serve as a package 10. However, the substrate 14 can also be arranged on an outer packaging. Preferably, the substrate 14 or individual parts of the substrate carrying the product carriers 16 with the products 11 are detachably arranged on the outer packaging, so that they can optionally be fed to a preferably electronic dispensing device. In other words, the package 10 can be combined with measures of the SF and CR described above.

The substrate 14 may have perforated or pre-punched areas through which the products 11 can be pressed out of the product carriers 16. As can be seen from FIG. 6, these regions can also be formed as an opening 20. The product carrier 16 or the sections 17 lie on one side (top or Bottom) on the substrate 14. On the other hand, the product carrier 16 may be at least partially covered by a cover element 21. In such cases, the product carriers 16 are sandwiched between the cover element 21 and the substrate 14. In this case, the cover element 21 likewise has openings 22 through which the nests 18 protrude with the products 11 (see in particular FIG. 6).

The package 10 is associated with further information 23, wherein this information 23 is attached as a package insert and / or arranged in printed form on the substrate 14 or other surfaces of the package 10. For example, information about the individual medicines, manufacturers or other relevant messages may be removably inserted into a slot. Information on patient data, date of manufacture of the products 11, treating physician, appropriate pharmacy, health insurance, manufacturing bottler, distributor, and others for unique association and / or traceability etc, as well as logos and brands of the manufacturer and other information may be printed on the package 10 , The information 12, 13, 23 may be printed and / or embossed (e.g., in Braille) or otherwise applied. In addition, e.g. For accounting reasons, a consecutive number or the like may be formed on the package 10. Also, the package may be attached to 10 media, audio media or other media.

Some of the information, in particular as to the contents of the package 10, may be used for purposes of simple inspection / comparison or e.g. with the recipe data also in coded form, for example, be arranged as barcode 24 or the like on the package 10. In principle, all information 12, 13, 23 can be embodied in legibly written form and / or as coding, for example, with a luminophore marking. In addition, the packaging 10 may have an electronic component 25, in particular a memory chip. By means of this device 25 is also a communication to external systems for purposes of control, testing or the like possible.

The above-described packaging 10 may be made manually or automatically. In this case, the most diverse types of packaging can be formed, for example a packaging 10 with one and the same product of a manufacturer or a packaging 10 with different products and / or the same products with different doses of an active ingredient of a manufacturer or a packaging 10 with products of different manufacturers. Any other combinations are also possible. Selected examples are explained below.

FIGS. 1 to 5 each show a packaging 10 which contains a "weekly ration" for a specific patient. In this case, in the packaging according to FIG. 1, which for example represents a possible therapy scheme for a long-term therapy of a chronic illness, six different products (A to F) of different manufacturers in z.T. stockpiled at different dosages. The number of products to be taken 11 varies. In addition to information about the manufacturer, the packaging 10 also carries product instructions (see in particular FIG. 2). In the package 10 according to FIG. 3, all products 11 which correspond to the active substance and the dosage are from a manufacturer. In addition to the manufacturer's instructions, information on the medicament itself (name, active substance, dosage, etc.) may alternatively also be indicated on the packaging 10. It can be seen from the package 10 of Figure 3 that in addition to sections 17 having one or two nests 18 in a field of the matrix, continuous section strips (e.g., from Monday to Thursday in the 8 o'clock line) may also be provided. In the packaging 10 according to FIG. 4, two medicaments from different manufacturers are assembled. The package 10 according to FIG. 5 individually provides the patient with three different products (drug I from manufacturer A, drug II from manufacturer B and drug III from manufacturer C) from three different manufacturers. In addition, another drug I of the manufacturer A with the same active ingredient in a lower dosage (administration time 20.00 clock) is part of the package 10. The manner of compilation is therefore arbitrary and may e.g. supplemented by additional vitamin supplements, supplements etc.

FIG. 7 shows by way of example a device 27 for producing the described packages 10. The device 27 has a transport element 28 for transporting individual blanks 29, which form the substrates 14, through which Device 27 and past a placement 30 over. Preferably, on both sides of the transport element 28 are provided receiving spaces 31 for rolls 32, magazines or the like, the rolls 32, magazines or the like preferably carrying rolled blister belts, folded or unfolded product carriers 16 or blister packs or other packaging types for the products 11. The placement head 30 is preferably arranged centrally and serves for transporting the product carrier 16 or sections 17 separated from the blister strip from a provision position 33 to the dispensing position on the substrate 14. The device 27 comprises a separating means for each receiving location 31, by means of which the product carriers 16 and / or Sections 17 can be separated from the roll 32, the magazine or other types of packaging. In the transport direction T at the output of the device 27, a printing station 34 is arranged, by means of which the information 12, 13, 23 can be placed on the packaging. The placement head 30 has a plurality of axes of movement (linear X, Y, Z axis and axis of rotation) and is optionally also linear and / or movable on a circular path and has a controller for automatic and individual execution of the individual manufacturing orders. The placement head is preferably connected to an optical reading device in order to check the correct recording of the sections 17 on-line by means of an optical code on the products 11 or the sections 17. For receiving and / or executing the orders, the device 27 can be networked and even be part of a network and thus, for example, integrated in a logistics system

• An der Vorrichtung 27 sind mehrere Rollen 32 mit aufgerollten Blistergurten gerüstet, wobei jeder Blistergurt lediglich einen Produkttyp (gleicher Wirkstoff in gleicher Dosierung) trägt und jedes einzelne Produkt 11 separat in einem Nest 18 des Blistergurtes liegt. Der Vorrichtung 27 wird ein Zuschnitt 29, beispielsweise das Substrat 14 zugeführt. Diese Zuschnitte 29 können für Patientengruppen,
• Verpackungsgruppen (Wochenpackung, Monatspackung etc) standardisiert und blanko oder vordergedruckt (z.B. mit Wochenkalender, Zeitskala oder dergleichen) ausgebildet sein. Der Vorrichtung 27 wird manuell oder automatisch ein Auftrag zur Herstellung einer Verpackung 10 gegeben, wobei der Auftrag die patientenspezifischen Daten (welches Medikament, welche Menge etc,) enthält. Sobald die Daten geladen sind, wird der Auftrag abgearbeitet, indem die Produkte 11 (eines oder mehrerer Hersteller und/oder einer oder mehrerer Dosierungen etc) ausgewählt und von den Rollen 32 bzw. den vorkonfektionierten Produktträgem 16 abgeschnitten oder anderweitig getrennt werden. Die vom Gurt getrennten Produktträger 16 bzw. Abschnitte 17 werden dann zur Bereitstellungsposition 33 gefördert und dort durch den über mehrere Achsen (z.B. X-, Y-, Z-Achse) bewegliche Bestückkopf 30 aufgenommen und dem Substrat 14 zugeführt. Zuvor kann das Substrat 14 mit Klebepunkten oder dergleichen versehen worden sein, wobei sich die Positionen der Klebepunkte aus der Anordnung der zu bestückenden Abschnitte 17 auf dem Substrat 14 ergeben. Die Abschnitte 17 werden auf die Klebepunkte gesetzt, so dass eine feste Verbindung zwischen den Abschnitten 17 und dem Substrat 14 entsteht. Andere Verbindungstechniken sind ebenfalls möglich. Nach der vollständigen Bestückung des Substrats 14 wird die korrekte Bestückung und Platzierung jedes Abschnittes 17 mittels optischer Verfahren überprüft und sodann das Deckelement 21 aufgebracht, das als Klappelement Teil des Zuschnitts 29 ist oder separat zugeführt wird. Der durch das mit mehreren Abschnitten 17 bestückte Substrat 14 gebildete Blisterverbund 19 wird dann der Bedruckstation 34 zugeführt und mit den gewünschten Informationen versehen. Anschließend wird die Verpackung 10 versandfertig vorbereitet. Anstelle der Rollen 32 können an der Vorrichtung 27 auch Magazine oder andere Verpackungstypen gerüstet sein. Die in Abschnitte 17 zu unterteilenden Blisterverpackungen oder dergleichen können auch in entrollter, gefalteter, ungefalteter oder anderer Darreichungsform an der Vorrichtung 27 vorrätig sein und verarbeitet werden.

The method for producing the packaging 10 described above is explained in more detail below:

• At the device 27 a plurality of rollers 32 are equipped with rolled up blister straps, each blister strip carrying only one product type (same active ingredient in the same dosage) and each product 11 is located separately in a nest 18 of the blister strip. The apparatus 27 is fed with a blank 29, for example the substrate 14. These blanks 29 can be used for patient groups,
• Packing groups (weekly pack, monthly pack etc) standardized and blank or front printed (eg with weekly calendar, time scale or the like) be formed. The device 27 is manually or automatically given an order to produce a package 10, wherein the order the patient-specific data (which drug, what amount etc,) contains. Once the data is loaded, the job is run by selecting the products 11 (one or more manufacturers and / or one or more dosages, etc.) and cutting or otherwise separating them from the rolls 32 or pre-assembled product carriers 16. The product carrier 16 or sections 17 separated from the belt are then conveyed to the provision position 33 and are picked up there by the placement head 30 which is movable over several axes (eg X, Y, Z axis) and fed to the substrate 14. Previously, the substrate 14 may have been provided with adhesive dots or the like, the positions of the adhesive dots resulting from the arrangement of the sections 17 to be loaded on the substrate 14. The sections 17 are placed on the adhesive dots, so that a firm connection between the sections 17 and the substrate 14 is formed. Other connection techniques are also possible. After the complete assembly of the substrate 14, the correct placement and placement of each section 17 is checked by means of optical methods and then the cover element 21 is applied, which is part of the blank 29 as a folding element or is supplied separately. The blister composite 19 formed by the substrate 14 populated with a plurality of sections 17 is then fed to the printing station 34 and provided with the desired information. Subsequently, the package 10 is prepared for shipment. Instead of the rollers 32, magazines or other types of packaging may also be provided on the device 27. The blister packs or the like to be subdivided into sections 17 may also be in stock on the device 27 in unrolled, folded, unfolded or other dosage form and processed.

Optionally, additional control and / or backup steps, e.g. be made by reading manufacturing, patient data or other information in the memory chip 25. By means of the coding 24 further testing or securing steps can be carried out. As described, the production of the packages 10 usually takes place automatically. In this case, job data (such as a recipe) can be fed directly to the device 27 and implemented by it. Usually, the method is computer-aided.

In abstract terms, the method can also be described as follows:
For the supply of patients with a patient-specific for a defined period of intake compiled need for a drug A and / or a drug B, it is proposed that the drug A in a plurality of separately housed spaced apart each spaced specimens EA of the drug A carrying carrier C and / or to provide the drug B in a carrier D carrying a plurality of each separately housed spaced apart specimens EB of the drug B, the carrier C portions CA with one or more specimens EA of the medicament A and / or the carrier D portions DB with one or more to separate a plurality of copies of the medicament B and to arrange the separated sections CA and / or DB in a matrix-like formation on a substrate in conformity with the intake.

With the above-described type of packaging and the method for producing the packaging, a particularly efficient and cost-effective method for the distribution of pharmaceutical and / or medical products 11 or packaging 10 can be realized, which will be described in more detail below. Concretely, the method can be exemplified by tablets e.g. proceed as follows: A distribution center manufactures patient-specific packaging. A client supplies the information necessary for putting together the packaging. The information may be transmitted verbally, in writing or usually in electronic form. Patients can be patients themselves as long as they are over-the-counter and non-pharmacy products / tablets. However, the information usually contains prescription data that is generated by a physician and transmitted by this or a pharmacy directly to the distribution center.

The tablets required for the collection of the desired content and quantity individual packaging can be supplied directly to the distribution center by different manufacturers. In the event that the tablets are delivered as raw materials to the distribution center, the distribution center fills the tablets themselves into blister straps so that the tablets are in pre-assembled blister straps for further processing. Each blister strip is associated with only one product of a specific active ingredient odr a special drug combination with a special dosage. On the blister belt itself is every nest of the Blister belt assigned to only one tablet. The individual packaging 10 is then assembled from these prefabricated blister straps. For the usual case of pills being filled in blister straps directly at the actual producer of the tablets, the manufacturers deliver the blister straps to the distribution center.

Depending on the catchment or supply area, the distribution center is regionally oriented. This means that the distribution center ensures the assembly and delivery of the individual packaging in a locally defined area. There are usually several regional distribution centers that can be supplied directly by the manufacturers. However, it may also be provided a national, national or international distribution center. The parent distribution center receives the tablets from one or more manufacturers in turn as raw materials and / or packed in blister straps. The blister belts and the blister belts filled with the raw material from the distribution center are then delivered either directly to one or more regional distribution centers and / or to a logistics unit, whereby the logistics unit may also be divided into several smaller units.

Regardless of the delivery of the distribution center producing the packages 10, the latter has stockpiled the most common and most widely prescribed products 11 as well as the most widely used combination products. This means that on the basis of detailed information and empirical values, those preparations are needed that are needed for the compilation of individual packages. Even if individual products 11 should not be available in the distribution center, these products 11 can be obtained at short notice from the manufacturer and / or from the higher-level distribution center and / or from the logistics unit.

The clients can be networked with the distribution center to transfer orders. The transfer of information can also be done by conventional means by e-mail or in other usual computer-aided way. The incoming orders can be processed within the distribution center by means of suitable devices 27 automatically and computer-controlled by the stocked blister belts the selected products 11 are separated in a predetermined amount and placed on a device 27 supplied blank, substrate 14 or the like. The resulting patient-specific blister packs or packaging 10 can then be labeled, coded or otherwise marked and tested before delivery, in particular with electronic aids.

In addition, the distribution center is optionally also connected to the logistics unit and / or the parent distribution center and / or the manufacturers. This connection can be made by conventional means of communication or ensured by a cross-linking. Also, several distribution centers can be networked together. Through the connections, in particular products 11 or blister belts can be supplied as required and / or order-controlled to the or each distribution center producing the packaging 10. Also, the stocking with the relevant products 11 or blister straps within the stations is easy to make sure.

The produced packaging 10 can be delivered by the distribution center itself or by the logistics unit quasi as a courier service to the client, for example a pharmacy or directly to the patient.

Claims (24)

Packaging (10) for pharmaceutical and / or medical products (11) and / or dietary supplements, comprising a substrate (14) which is equipped with patient-specific products (11) for a defined period of time and with instructions for the application or administration time for the patient is provided, characterized in that on the substrate (14) one or more prefabricated product carrier (16) with the patient-specific products (11) are arranged for a defined period of time, each product carrier (16) is part of a blister pack and only products (11 ) carries a special active ingredient or a special combination of active ingredients in a specific dosage. Packaging according to claim 1, characterized in that the substrate (14) carries or forms a blister composite (19), such that a plurality of sections (17) of the product-specific blister packs, each with different products (11) from one or more manufacturers on the Substrate (14) are applied, Packaging according to claim 2, characterized in that in each nest (18) of each blister pack or each section (17) of the blister packs exactly one product (11) is arranged. Packaging according to one of claims 1 to 3, characterized in that the product carrier (16) or sections (17) are fixedly connected to the substrate (14). Packaging according to claim 4, characterized in that the product carrier (16) or the sections (17) are adhesively bonded to the substrate (14). Packaging according to one of claims 1 to 5, characterized in that the substrate (14) is detachably arranged on an outer packaging. Packaging according to one of claims 1 to 6, characterized in that the or each product carrier (16) between the substrate (14) and a cover element (21) is arranged. Packaging according to one of claims 1 to 7, characterized in that the substrate (14) or the Produktträgem (16) information (12, 13) are assigned to days of the week and time of taking or application of the products (11). Packaging according to one of claims 1 to 8, characterized in that on the substrate (14) information (23) to the patient and / or to the or each product (11) and / or to the manufacturers are shown. Packaging according to claim 8 or 9, characterized in that the information (12, 13, 23) as a legible real font and / or as an encoding on the package (10) are shown. Packaging according to one of claims 1 to 10, characterized in that the substrate (14) is associated with an electronic component (25) for storing data and / or information. Packaging according to one of claims 1 to 11, characterized in that it is produced fully automatically. Process for producing a packaging for pharmaceutical and / or medical products (11) and / or dietary supplements, characterized by the following steps: Providing a substrate (14), - selecting patient-specific products (11) for a defined period of time, - Separating pre-assembled product carrier (16) with the selected patient-specific products (11) of blister packs, each product carrier (16) excluding products (11) of a special Active ingredient or a special combination of active ingredients in a special dosage contributes, and - Loading the substrate (14) with the separated Produktträgem (16). A method according to claim 13, characterized in that the or each product carrier is separated from a blister strip. A method according to claim 13 or 14, characterized in that by applying a plurality of sections of the product-specific blister packs, a blister composite (19) is formed, wherein the blister composite (19) can be formed from product carriers (16) with products (11) from different manufacturers. Method according to one of claims 13 to 15, characterized in that the or each product carrier (16) is glued to the substrate (14). Method according to one of claims 13 to 16, characterized in that after the loading of the substrate (14) with the product carriers (16), a cover element (21) is applied to the substrate (14), so that the or each product carrier (16) between the cover element (21) and the substrate (14) is arranged. Method according to one of claims 13 to 17, characterized in that the substrate (14) or, the product carrier (16) with information (12, 13) on weekdays and time of ingestion or application is characterized . Method according to one of Claims 13 to 18, characterized in that information (23) relating to the patient and / or to the or each product (11) and / or to the manufacturers is printed on the substrate (14). Method according to one of claims 13 to 19, characterized in that manufacturing and / or product information in an electronic component (25) of the substrate are read. Method according to one of claims 13 to 20, characterized in that the selection of the patient-specific products (11) is based on a recipe. Method according to one of claims 13 to 21, characterized in that the packaging (10) is produced automatically, Method according to one of claims 13 to 22, characterized in that it is carried out computer-assisted. A method according to claim 22 or 23, characterized in that the patient information with the respective individual medication directly from the doctor or a pharmacy or clinic or other authorized persons on-line to a device (27) for assembling the package (10) are directed.

Images